TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,419,000 | -63.4% | 77,956 | -67.1% | 0.03% | -57.1% |
| Q3 2021 | $3,878,000 | -2.1% | 236,770 | +0.6% | 0.08% | -1.3% |
| Q2 2021 | $3,961,000 | +178.9% | 235,338 | +202.6% | 0.08% | +136.4% |
| Q1 2021 | $1,420,000 | +0.1% | 77,780 | -0.2% | 0.03% | -5.7% |
| Q4 2020 | $1,419,000 | -9.3% | 77,955 | -11.2% | 0.04% | -20.5% |
| Q3 2020 | $1,565,000 | -7.5% | 87,739 | -7.0% | 0.04% | -15.4% |
| Q2 2020 | $1,692,000 | +8.8% | 94,366 | -7.9% | 0.05% | -7.1% |
| Q1 2020 | $1,555,000 | -31.0% | 102,448 | -10.2% | 0.06% | -15.2% |
| Q4 2019 | $2,252,000 | -22.0% | 114,130 | -32.0% | 0.07% | -28.3% |
| Q3 2019 | $2,887,000 | -21.2% | 167,871 | -18.9% | 0.09% | -20.7% |
| Q2 2019 | $3,665,000 | -26.1% | 207,113 | -15.0% | 0.12% | -26.1% |
| Q1 2019 | $4,962,000 | – | 243,589 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |